Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 4/1997

Content (15 Articles)

ORIGINAL ARTICLE

A randomized study comparing VMCP and MMPP in the treatment of multiple myeloma

E. Nagura, Atsushi Ichikawa, Osamu Kamiya, Ryoichi Kato, Makoto Utsumi, Masao Tanaka, Hideo Takeyama, Kazuyuki Shimizu, Masahide Kobayashi, Kazuyuki Naito, Hiroshi Nishiwaki, Harumitsu Mizuno, Noriyuki Hirabayashi, Masakazu Nitta, Yasuharu Kato, Toshihiko Shibata, Tomomitsu Hotta, Kohei Kawashima, Hidehiko Saito

ORIGINAL ARTICLE

Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics

B. A. Conley, Merrill J. Egorin, Rajeshwari Sridhara, Rebecca Finley, Ramzi Hemady, Suhlan Wu, Nancy S. Tait, David A. Van Echo, David A. Van Echo

ORIGINAL ARTICLE

A phase I study of 5-fluorouracil, leucovorin and levamisole

J. F. Cleary, Rhoda Arzoomanian, Donna Alberti, Chris Feierabend, Barry Storer, Pauline Witt, P. P. Carbone, George Wilding

ORIGINAL ARTICLE

Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea

Shekar N. Kurpad, M. Eileen Dolan, Roger E. McLendon, Gerald E. Archer, Robert C. Moschel, Anthony E. Pegg, D. D. Bigner, Henry S. Friedman

ORIGINAL ARTICLE

A sequential Bayesian algorithm for dose individualisation of carboplatin

S. B. Duffull, Evan J. Begg, Bridget A. Robinson, John J. Deely

ORIGINAL ARTICLE

A phase I study of irinotecan and infusional cisplatin for advanced non-small-cell lung cancer

K. Mori, Tsukasa Ohnishi, Kohki Yokoyama, Keigo Tominaga

ORIGINAL ARTICLE

Augmentation of vincristine cytotoxicity by megestrol acetate

Sualp Tansan, Yener Koç, Hayri Aydin, Godofredo Urbano, R. McCaffrey

ORIGINAL ARTICLE

A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis

D. L. Trump, David C. Smith, Dwight Stiff, Adedayo Adedoyin, Roger Day, Robert R. Bahnson, Janie Hofacker, Robert A. Branch

CLINICAL TRIAL REPORT

High-dose carmustine for high-grade gliomas in childhood

Eric Bouffet, Fatima Khelfaoui, Irène Philip, Pierre Biron, M. Brunat-Mentigny, Thierry Philip

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine